Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-08-01
1998-08-25
Fan, Jane
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514385, 514210, 514218, A61K 31505
Patent
active
057983607
ABSTRACT:
Compositions are provided comprising novel di-nitrogen heterocycle compounds containing N-(aminoalkyl) and/or N-(amidoalkyl) groups. An additional situs of functionality is also provided. The compounds and compositions of the invention are useful as antibacterial and other pharmaceutical agents and as intermediates for preparation of other pharmaceutical agents. In addition, compounds of the present invention are useful as research reagents including employment as species for effecting combinatorial synthesis.
REFERENCES:
patent: 4988814 (1991-01-01), Abou-Gharbia et al.
patent: 5143854 (1992-09-01), Pirrung et al.
patent: 5449754 (1995-09-01), Nishioka
patent: 5472672 (1995-12-01), Brennan
patent: 5489678 (1996-02-01), Fodor et al.
PCT International Search Report dated Jan. 14, 1998, 2 pages.
Bourrain, S. et al., "Isoxazole and pyrazole derivatives as dopamine receptor subtype ligands, and their preparation, compositions, and use", Jun. 1, 1995, Database CAPLUS on STN, Document No. 123:169618 (Abstract Only).
Debernardis, J.F. et al., "Preparation of 1-aryl-3-piperazineopropanones for treatment of Alzheimer's disease", May 30, 1996, Database CAPLUS on STN, Document No. 125:142771 (Abstract Only).
Ferrini, P.G. et al., "Preparation of substituted benzoyl-and benzylphenethylpiperazines as analgesics", Dec. 23, 1987, Database CAPLUS on STN, Document No. 108:112502 (Abstract Only).
Krishnan, R. et al., "Antibacterial activity of 6,8-disubstituted-quinolone-3-carboxylic acids", J. Pharm. Sci., 1986, 75(12), 1185-1187, Document No. 106:156251 (Abstract Only).
Meyer, W.E. et al, "5-(1-Piperazinyl)-1H-1,2,4-triazol-3-amines as antihypertensive agents", J. Med. Chem., 1989, 32(3), 593-597, Document No. 110:205054 (Abstract Only).
Modak, S.M. et al., "Pharmaceutical compositions for inactivating irritants in fluids containing antimicrobial agents", Oct. 5, 1995, Database CAPLUS on STN, Document No. 124:66587 (Abstract Only).
Protiva, M. et al., "Part IV. 1-Aryl-and 1-(arylmethyl)-4-guanylpiperazines and other heterocyclic and alicyclic guanidine derivatives", Collect. Czech. Chem. Commun., 1975, 40(12), 3904-3923, Document No. 84:180165 (Abstract Only).
Tamada, S. et al., "Preparation of 4-oxoquinolines as cardiotonics, vasodilators, and inflammation inhibitors", Mar. 8, 1989, Database CAPLUS on STN, Document No. 111:194610 (Abstract Only).
Tone, H. et al., "Preparation of pyrazine oxides as drugs", Nov. 4, 1992, Database CAPLUS on STN, Document No. 118:124562 (Abstract Only).
Yaso, M. et al., "Preparation of 1-(substituted alkyl)-2(1H)-pyrazinones as cardiovascular agents", Sep. 2, 1987, Database CAPLUS on STN, Document No. 108:167501 (Abstract Only).
Achari et al., "Facing up to Membranes: Structure/Function Relationships in Phospholipases", Cold Spring Harbor Symp. Quant. Biol., 1987, 52, 441-452.
Bomalaski et al., "Human Extracellular Recombinant Phospholipase A.sub.2 Induces an Inflammatory Response in Rabbit Joints", J. Immunol., 1991, 146(11), 3904-3910.
Burack et al., "Role of Lateral Phase Separation in the Modulation of Phospholipase A.sub.2 Activity", Biochemistry, 1993, 32, 583-589.
Campbell et al., "Inhibition of Phospholipase A.sub.2 ; a Molecular Recognition Study", J. Chem. Soc. Chem. Commun., 1988, 1560-1562.
Cho et al., "The Chemical Basis for Interfacial Activation of Monomeric Phospholipases A.sub.2 ", J. Biol. Chem., 1988, 263(23), 11237-11241.
Davidson et al., "Inhibition of Phospholipase A.sub.2 by Lipocortins and Calpactins", J. Biol. Chem., 1987, 262(4), 1698-1705.
Davidson et al., "1-Stearyl,2-Stearoylaminodeoxy Phosphatidylcholine, A Potent Reversible Inhibitor of Phospholipase A.sub.2 ", Biochem. Biophys. Res. Commun., 1986, 137(2), 587-592.
Dennis, E.A., "Phospholipases", The Enzymes, Boyer, P.D. (ed.), Academic Press, New York, 1983, vol. 16, 307-353.
Essien, H., "Synthesis of Diethylenetriaminepentaacetic Acid Conjugated Inulin and Utility for Cellular Uptake of Liposomes", J. Med. Chem., 1988, 31, 898-901.
Franson et al., "Phospholipid metabolism by phagocytic cells. Phospholipases A.sub.2 associated with rabbit polymorphonuclear leukocyte granules", J. Lipid Res., 1974, 15, 380-388.
Glaser et al., "Phospholipase A.sub.2 enzymes: regulation and inhibition", TiPs Reviews, 1993, 14, 92-98.
Grainger et al., "An enzyme caught in action: direct imaging of hydrolytic function and domain formation of phospholipase A.sub.2 in phosphatidylcholine monolayers", FEBS Lett., 1989, 252(1,2), 73-82.
Lombardo et al., "Cobra Venom Phospholipase A.sub.2 Inhibition by Manoalide", J. Biol. Chem., 1985, 260(12), 7234-7240.
Marki et al., "Differential inhibition of human secretory and cytosolic phospholipase A.sub.2 ", Agents Actions, 1993, 38, 202-211.
Miyake et al., "The Novel Natural Product YM-26567-1 henyl)chroman!: A Competitive Inhibitor of Group II Phospholipase A.sub.2 ", J. Pharmacol. Exp. Ther., 1992, 263(3), 1302-1307.
Noel et al., "Phospholipase A.sub.2 Engineering. 3. Replacement of Lysine-56 by Neutral Residues Improves Catalytic Potency Significantly, Alters Substrate Specificity, and Clarifies the Mechanism of Interfacial Recognition", J. Am. Chem. Soc., 1990, 112, 3704-3706.
Oinuma et al., "Synthesis and Biological Evaluation of Substituted Benzenesulfonamides as Novel Potent Membrane-Bound Phospholipase A.sub.2 Inhibitors", J. Med. Chem., 1991, 34, 2260-2267.
Pruzanski et al., "Enzymatic Activity and Immunoreactivity of Extracellular Phospholipase A.sub.2 in Inflammatory Synovial Fluids", Inflammation, 1992, 16(5), 451-457.
Sampson, B.A. et al., "Identification and Characterization of a New Gene of Escherichia coli K-12 Involved in Outer Membrane Permeability", Genetics, 1989, 122, 491-501.
Scott et al., "Interfacial Catalysis: The Mechanism of Phospholipase A.sub.2 ", Science, 1990, 250, 1541-1546.
Pon, R.T., "Solid Phase Supports in Oligonucleotide Synthesis", Protocols for Oligonucleotides and Analogs: Synthesis and Properties, Agrawal, S., ed., Humana Press, 1993, 20, 465-496.
Tanaka et al., "A Novel Type of Phospholipase A.sub.2 Inhibitor, Thielocin A1.beta., and Mechanism of Action", J. Antibiotics, 1992, 45(7), 1071-1078.
Vishwanath et al., "Edema-Inducing Activity of Phospholipase A.sub.2 Purified from Human Synovial Fluid and Inhibition by Aristolochic Acid", Inflammation, 1988, 12(6), 549-561.
Vloon, W.J. et al., "Synthesis and Biological Properties of Side-Chain-Modified Bleomycins", J. Med. Chem., 1987, 30, 20 -24.
Washburn et al., "Suicide-inhibitory Bifunctionally Linked Substrates (SIBLINKS) as Phospholipase A.sub.2 Inhibitors", J. Biol. Chem., 1991, 266(8), 5042-5048.
Wery et al., "Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A.sub.2 at 2.2 .ANG. resolution", Nature, 1991, 352, 79-82.
Yang et al., "Studies on the status of lysine residues in phospholipase A.sub.2 from Naja naja atra (Taiwan cobra) snake venom", Biochem. J., 1989, 262, 855-860.
Yuan et al., "Synthesis and Evaluation of Phospholipid Analogues as inhibitors of Cobra Venom Phospholipase A.sub.2 ", J. Am. Chem. Soc., 1987, 109, 8071-8081.
Yuan, J. et al., "Synthesis of Some 2-Substituted Aminobenzothiazoles", Acta Scientiarum Naturalium, (Beijing Daxue Zuebao, Ziran Kexueban), 1988, 24(4), 504-506 (English Abstract).
Maffrand et al.. CA 87:85048, 1977.
Cook Phillip Dan
Kawasaki Andrew M.
Kung Pei Pei
Fan Jane
ISIS Pharmaceuticals Inc.
LandOfFree
N-(aminoalkyl)- and/or N-(amidoalkyl)- dinitrogen heterocyclic c does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(aminoalkyl)- and/or N-(amidoalkyl)- dinitrogen heterocyclic c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(aminoalkyl)- and/or N-(amidoalkyl)- dinitrogen heterocyclic c will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-36534